Insiders · Profile

ARCH Venture Fund XIII, L.P.

10% owner at Lyell Immunopharma. Filing since 6 Mar 2026. CIK 0002006772

Company

Date

Role

Action

Shares

Amount

Of holding

LYEL Lyell Immunopharma, Inc.

6 Mar 2026

10% owner

Bought

488,090

$12.50M

52.0%

1 decision on file.